EXTON, Pa., Oct. 1 /PRNewswire/ -- Othera Pharmaceuticals, Inc., a specialty pharmaceuticals company focused on novel, patient-administered products for ophthalmology, oncology, and inflammatory disease, has announced the appointment of Frederick R. Rickles, MD as Chief Scientific Officer effective immediately. In this position, Dr. Rickles will lead the development, integration and execution of Othera’s research and clinical development programs.
